from the Hussman Institute for Human Genomics
Hi Jeffrey and Cecile:
This looks very interesting. Read below. It's a result of my Alzheimer's article.
Forwarded message
From: Brandt, Susan
Date: Thu, Jun 21, 2012 at 10:35 AM
Subject: Genomic research
To: ' 'c
The John P. Hussman Institute for Human Genomics has as its leader, Dr. Margaret A. Pericak-Vance, the woman whose team discovered the APoE4 gene and identified it as a risk gene for Alzheimer's disease. Her work has been cited 25,172 times by other researchers. Last year, she was part of an international consortium that identified ten more genes related to Alzheimer's risk.
Dr. Pericak-Vance excels at the integration of genomic and statistical technologies and their application to diseases of public health importance in general, and to neurologic diseases in particular. John Hussman, Ph.D., president of the Hussman Funds in New York, sought out Dr. Pericak-Vance for her expertise in autism genomics when his child was diagnosed with autism. They worked together to develop a stronger statistical/mathematical program for analyzing the massive amounts of autism data. I have attached an article from Fortune magazine about that effort.
The Hussman Institute is the largest genomics research center in the Southeastern U.S. I am writing to see if there would be an opportunity for us to speak with your organization about our research and discoveries. Dr. Pericak-Vance travels extensively and we could arrange something around her travel schedule but we would especially like to invite you and/or Mr. Epstein to come visit the labs!
Please let me know if we might schedule something to begin the conversation.
Sincerely,
Sue Brandt
EFTA00877310
Susan Blair Brandt, M.Ed., CFRE
Executive Director of Development
John P. Hussman Institute for Human Genomics
University of Miami. Miller School of Medicine
1501 NW 10th Avenue (M-860). BRB-328
Miami, Florida 33136
(office)
(cell)
"Philanthropy lies at the very heart of human greatness." J. Patrick Ryan
The information contained in this transmission may contain privileged and confidential information, including patient information protected by federal and state privacy laws. It is intended only for the use of the person(s) named above. If you are not the intended recipient. you are hereby notified that any review, dissemination, distribution or duplication of this communication is strictly prohibited. If you are not the intended recipient. please contact the sender by reply email and destroy all copies of the original message.
EFTA00877311